The Phase I clinical trial is a randomized, single-blind, placebo-controlled, single-ascending dose study to evaluate the safety, pharmacokinetics and pharmacodynamics of orally administered ARRY-300 in healthy volunteers. Kevin
Before joining ImmunoGen, Mr Perry was CFO of Elixir Pharmaceuticals, where he was extensively involved in partnering and fundraising activities. Prior to Elixir, he was CFO of Domantis,
This double-blind, randomized, placebo-controlled Phase I/IIa clinical study is designed to investigate the safety, tolerability and efficacy on pain with ESBA105 applied locally via intra-articular administration to patients
Under the agreement, Medica Nord will be responsible for all investments related to distribution and marketing. The company already has experience of some of Scandinavian Clinical Nutrition’s (SCN)
The agreement focuses on the continued development of Sirius’s pharmacogenomic diagnostic for responsiveness to recombinant activated Protein C (sold by Eli Lilly and company under the trademark Xigris).
Integra expects to maintain Omni-Tract’s operations in Minnesota and will integrate Omni-Tract’s product lines into its combined offering of Jarit, Padgett, R&B Redmond, and Luxtec lines of surgical
Ms Zhao has obtained her certified general accountant designation from Canada in 1996 and her MSc in finance from the University of British Columbia in 1998. Genhui Chen,
Naprelan is a once-daily, controlled-release formulation of naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of a number of conditions, including osteoarthritis, rheumatoid arthritis and
Mr Kochersperger has over two decades of product development and commercialization experience at life sciences tools companies. He will lead the team focusing on the commercial design and
NovaBay has recently filed additional patent applications including ones for compositions of matter of additional Aganocide compounds, methods of use and formulations, and is preparing further applications in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.